Related Experiment Video
Updated: Sep 14, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
What Is the Optimal Perioperative Treatment for Variant Subtypes of Bladder Cancer?
1GU Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.
Abstract:
Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Kidney Transplant II: Surgical Procedure
Urinary Tract Calculi III: Medical Management